Generalized tonic-clonic seizure (GTCS), also known as grand mal, is a serious neurological disorder characterized by sudden loss of consciousness, tonic and clonic convulsions that occur simultaneously in both hemispheres of the brain. This type of seizure is the most prominent manifestation of epilepsy, a disorder in which excessive electrical activity of neurons occurs, leading to disruption of normal brain function. Generalized tonic-clonic seizures can manifest as prolonged and distressing episodes that can cause serious injury and negatively affect the patient's quality of life.
History of the disease and interesting historical facts
The history of epilepsy research goes back several millennia. Ancient texts such as the Hippocratic Works (c. 400 BC) first mention the non-composable nature of seizures. Hippocrates believed that epilepsy had natural causes and was not a "sacred disease" as many of his contemporaries believed. In the Middle Ages, the disease was often associated with possession and was considered the result of demonic activity. It was only in the 19th century, with the development of neurophysiology, that a systematic study of the pathology began, defining epilepsy as a dysfunction of the brain. In the 20th century, a breakthrough in the treatment of the disease occurred: the use of anticonvulsants began, as well as studies using magnetic resonance imaging, which significantly improved the diagnosis and treatment of the disease.
Epidemiology
According to the World Health Organization, epilepsy affects more than 50 million people worldwide, of whom approximately 20% have generalized forms of the disease, including GTCS. The prevalence of the disease varies significantly depending on the region, level of health care, and socio-economic status. In particular, in developing countries, the incidence of epilepsy can reach 1% of the population, while in developed countries this figure remains below 0.5%. According to studies, the average age of onset of the first symptoms of GTCS is approximately 5-20 years, which emphasizes the importance of early diagnosis and intervention.
Genetic predisposition to this disease
Some forms of epilepsy, including GTCS, have a genetic predisposition. Research has shown that certain mutations in genes that control ion channels can contribute to the development of generalized seizures. For example, mutations in the SCN1A, SCN2A, and KCNQ2 genes have been linked to a hereditary form of epilepsy. Multifactorial mechanisms have also been implicated, with the interaction of different genes and the environment contributing to seizures. However, it is important to note that having a mutation does not always result in the development of the disease, highlighting the complexity of genetic analysis.
Risk factors for the development of this disease
There are various risk factors that may contribute to the development of generalized tonic-clonic seizures. These include:
- Heredity - a family history of epilepsy;
- Head injuries - Traumatic brain injuries can cause changes in brain function;
- Infections - such as meningitis or encephalitis - can cause damage to neurons;
- Alcoholism - abruptly stopping alcohol consumption can trigger an attack;
- Hemorrhages and tumors can lead to disruption of the brain's electrical activity.
Diagnosis of this disease
Diagnosis of GTCS involves a number of methods and approaches. The main symptoms to look out for include:
- Sudden loss of consciousness;
- Muscle cramps that affect the entire body;
- Post-ictal disorientation and fatigue.
Laboratory tests include tests for infections and metabolic disorders. Radiological methods such as MRI and CT can help identify structural changes in the brain. Additionally, EEG is performed to record the electrical activity of neurons. An important step in diagnosis is differential diagnosis, which may include various conditions such as psychogenic seizures.
Treatment
Treatment of GTCS can be complex and individualized. Pharmacological treatment is used, which usually includes anticonvulsants such as valproic acid, lamotrigine, and carbamazepine. In some cases, when medications are ineffective, surgical intervention, such as resection of the epileptic focus, is considered. Other treatments may include:
- Ketogenic diet - used for children;
- Stimulation devices - stimulating devices that can help reduce the number of seizures;
- Psychotherapy – to improve control over the patient’s condition and emotional state.
List of medications used to treat this disease
- Valproic acid;
- Carbamazepine;
- Lamotrigine;
- Gabapentin;
- Topiramate.
Disease monitoring
Monitoring of generalized tonic-clonic seizures includes regular consultations with a neurologist, as well as periodic EEG. The prognosis of the disease depends on its etiology and the effectiveness of treatment. Major complications may include:
- Injuries during an attack;
- Cognitive impairment;
- Mental disorders;
- Status epilepticus is a dangerous complication that requires immediate care.
Age-related features of the disease
Generalized tonic-clonic seizures may present at different ages. In children, they are often the result of developing epilepsy, while in older people, cases are usually associated with acquired causes such as stroke or tumors. In adolescents and young adults, GTCS may begin with academic and social stress that exacerbate the symptoms of the disorder. It is important to note that lifestyle and support from family and specialists are of great importance for patients at any age.
Questions and Answers
- What is a generalized tonic-clonic seizure? It is a serious neurological condition characterized by seizures and loss of consciousness.
- How is GTCS treated? Treatment may include antiepileptic drugs, surgery, and lifestyle changes.
- What are the causes of GTCS? Causes can be both genetic and acquired factors, including injuries and infections.
- What tests are needed for diagnosis? EEG, MRI, CT and other laboratory tests are performed.
- What is the prognosis for patients with GTCS? The prognosis depends on the cause and response to treatment; with timely therapy, significant improvement is possible.
Dr. Oleg Korzhikov offers some advice for patients with generalized tonic-clonic seizures. He emphasizes the importance of following the medication regimen, avoiding stressful situations, and maintaining a healthy lifestyle. “It is important to inform others about your illness so that if an attack occurs, they know what to do. Record all episodes of seizures to track the frequency and possible triggers. In addition, regular consultations with your doctor will help adjust treatment and identify possible complications in time,” the doctor notes.
